PDLI PDL BioPharma Inc.

$2.905 -2.52%

1,311,802 Shares Traded
1,843,240 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $1.19 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-3.83%
If Intiated One Month Ago, Shorts Have Realized a Return of:-21.63%
If Initiated Five Days ago, Shorts Have Realized a Return of:-4.2%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 10.88%
Short Interest15.93 million
Float146.45 million
Short Ratio12.05
Market Cap$458.36 million
Market Maker ActivityDaily Short Volume


Neo Performance Materials: A Good Story Shot Down By A Clear Risk (SeekingAlpha)
PDL BioPharma (PDLI) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow (SeekingAlpha)
PDL BioPharma, Inc. 2017 Q4 - Results - Earnings Call Slides (SeekingAlpha)
Premarket Gainers as of 9:05 am (03/09/2018) (SeekingAlpha)
PDL Bio Q4 top line up 2%; earnings up 317%; shares up 26% premarket (SeekingAlpha)
Wall Street Breakfast: Jobs And Wages In Focus (SeekingAlpha)
PDL BioPharma's (PDLI) CEO John McLaughlin on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
PDL BioPharma beats by $0.12, beats on revenue (SeekingAlpha)
PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results (PR Newswire)
Notable earnings after Thursday's close (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 89.1%

Earnings Stats

PE Ratio 4.46
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $2.82
50 Day Moving Average $2.7
52 Week High $3.55
52 Week Low $1.96

Data provided for free by IEX. Questions? Read the FAQ